Senior insider sale
Principal Accounting Officer at MONTE ROSA THERAPEUTICS, INC. — senior position signals high conviction
$1.44M
78.15K shares
What this filing means
DUNN EDMUND plans to sell 78.15K shares of MONTE ROSA THERAPEUTICS, INC. valued at approximately $1.44M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/23/2026ACC: 0001950047-26-006406
Officer· Principal Accounting Officer
Since Mar 2026
78.15K
Shares to sell
$1.44M
Approx. market value
16.66K
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months1
Stock Option Exercise
Cash
6/23/2026
16.66KTotal acquired16.66K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/23/2026 | Stock Option Exercise Cash | 16.66K | — |
| Total | 16.66K | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
18.68K
Market value
$345.6K
4/16/2026
—Completed
Units to sell
16.69K
Market value
$300.4K
4/13/2026
—Completed
Units to sell
26.12K
Market value
$450.6K
4/8/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
16.66K
Market value
$345.0K
6/23/2026
Total
Units
78.15K
Value
$1.44M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
4/16/2026 | 18.68K | $345.6K | — | Completed |
4/13/2026 | 16.69K | $300.4K | — | Completed |
4/8/2026 | 26.12K | $450.6K | — | Completed |
| Planned — Approximate Date | ||||
6/23/2026 | 16.66K | $345.0K | NASDAQ | Planned |
| Total | 78.15K | $1.44M | ||